VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
End-range mobilization
Preclinical
Biologic
U
University of Pecs
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Pain Threshold
Completed
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Pain Threshold
Preclinical
Completed
Clinical
Trials by Indication
[1]
Pain Threshold
1 trial
End-range Mobilization on Time Curve of Pressure Pain Threshold
Completed
·
U
University of Pecs
·
N/A
·
NCT04629625
·
66 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for End-range mobilization. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
End-range mobilization compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for End-range mobilization. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
University of Pecs company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Biologic
[2]
Highest Phase
Preclinical
[1]
Company
U
University of Pecs
Related News